Marlène Dufresne (from the team led by Pierre Cordelier, CRCT), working in close collaboration with the Proteomics Platform of the CRCT Technology Cluster, has just published an article on protein biomarkers for the pre-neoplastic stages of pancreatic cancer. For the first time, this preclinical study using several mouse models that mimic the human disease has revealed the identity of plasma proteins that discriminate the different pre-neoplastic stages of PanIN (Pancreatic Intraepithelial Neoplasia) before the appearance of tumours. This study presages opportunities for the development of non-invasive approaches for the prediction and early detection of pancreatic adenocarcinoma.
You can see the article and its PubMed link on the Bibliography page.
Definitely a good read.